Story
China Pharma Shares Plunge 69% on Discounted $5 Million Stock Offering

Shares of China Pharma Holdings Inc. (NYSE American: CPHI) plummeted 69% in trading on Wednesday after the company announced a registered direct offering priced at a substantial discount.
Details of the Offering
China Pharma disclosed in a statement that it had entered into an agreement to sell 2.5 million shares of its common stock at a price of $2.00 per share. The offering is expected to generate gross proceeds of approximately $5 million before deducting placement agent fees and other expenses.
The company stated that it intends to use the net proceeds for working capital and general corporate purposes. The transaction is anticipated to close on or about July 23, 2026, with FT Global Capital, Inc. acting as the exclusive placement agent.
AdMarket Impact and Context
The sharp decline in the company's stock price reflects significant shareholder dilution resulting from the new share issuance. Offerings priced well below the current market price, as is implied by the market's reaction, can trigger a sell-off as the stock's value adjusts downward toward the new, lower offering price.
China Pharma Holdings is a specialty pharmaceutical company that develops, manufactures, and markets products in China. The company focuses on treatments for conditions with high incidence rates, such as cardiovascular and infectious diseases, and operates through its subsidiary, Hainan Helpson Medical & Biotechnology Co., Ltd.
Read next
More on Stocks
FTC Orders Walmart, Uber, Delta to Disclose Data on Personalized Pricing
The U.S. Federal Trade Commission is demanding nine major companies, including leading retail, travel, and gig economy firms, to provide information on how they use consumer data for setting individual prices and wages.

Google Launches Gemini 4 Carbon AI Model to Bolster Cybersecurity Capabilities
Alphabet's Google has unveiled Gemini 4 Carbon, its latest AI model specifically designed for advanced cybersecurity tasks like vulnerability detection and secure code generation. The launch escalates competition with rivals OpenAI and Anthropic in the enterprise AI market.

Oracle Shares Surge After Unveiling $225 Billion Revenue Target for 2030
Oracle stock rose sharply after the company presented a long-term financial outlook targeting at least $225 billion in annual revenue by fiscal 2030, driven by its expanding AI infrastructure business.

DOJ Scrutinizes Nvidia's $12.9B Hugging Face Deal Amid Broader Antitrust Probe, Sources Say
The U.S. Department of Justice is reportedly examining Nvidia's planned $12.93 billion acquisition of AI platform Hugging Face as part of a wider, ongoing antitrust investigation into the chipmaker's market conduct.